Comparison between Aakaar Medical Technologies IPO and Solvex Edibles IPO.
Aakaar Medical Technologies IPO is a SME Fixed Price IPO proposed to list at NSE SME while Solvex Edibles IPO is a SME Fixed Price proposed to list at BSE SME.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Indorient Financial Services Ltd. | Corporate Makers Capital Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | JSK Securities & Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aakaar Medical Technologies IPO is up to ₹25.64 Cr whereas the issue size of the Solvex Edibles IPO is up to ₹17.93 Cr. The final issue price of Aakaar Medical Technologies IPO is ₹72.00 per share and of Solvex Edibles IPO is ₹72.00 per share.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹68.00 per share | |
| Issue Price (Upper) | ₹72.00 per share | |
| Issue Price (Final) | ₹72.00 per share | ₹72.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 35,61,600 shares | 24,89,600 shares |
| Fresh Issue Size (Amount) | up to ₹25.64 Cr | up to ₹17.93 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,61,600 shares | 24,89,600 shares |
| Issue Size Total (Amount) | up to ₹25.64 Cr | up to ₹17.93 Cr |
Aakaar Medical Technologies IPO opens on Jun 20, 2025, while Solvex Edibles IPO opens on Sep 22, 2025. The closing date of Aakaar Medical Technologies IPO and Solvex Edibles IPO is Jun 24, 2025, and Sep 26, 2025, respectively.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | |
|---|---|---|
| Anchor Bid Date | Jun 19, 2025 | |
| Issue Open | Jun 20, 2025 | Sep 22, 2025 |
| Issue Close | Jun 24, 2025 | Sep 26, 2025 |
| Basis Of Allotment (Tentative) | Jun 25, 2025 | Sep 29, 2025 |
| Initiation of Refunds (Tentative) | Jun 26, 2025 | Sep 30, 2025 |
| Credit of Share (Tentative) | Jun 26, 2025 | Sep 30, 2025 |
| Listing date (Tentative) | Jun 27, 2025 | Oct 01, 2025 |
| Anchor Lockin End date 1 | Jul 25, 2025 | |
| Anchor Lockin End date 2 | Sep 23, 2025 |
Aakaar Medical Technologies IPO P/E ratio is 12.43, as compared to Solvex Edibles IPO P/E ratio of 11.15.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aakaar Medical Technologies Ltd.'s revenue increased by 33% and profit after tax (PAT) rose by 110% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Solvex Edibles Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 305% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.11 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.01 | 70.72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.43 | 11.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹102.04 Cr. | ₹64.45 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.69% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.02% | 24.51% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.79 | ₹6.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 33.81% | 20.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aakaar Medical Technologies IPO Retail Individual Investors (RII) are offered 12,48,000 shares while in Solvex Edibles IPO retail investors are offered 12,48,000 shares. Qualified Institutional Buyers (QIB) are offered 7,12,000 shares in Aakaar Medical Technologies IPO and 0 shares in Solvex Edibles IPO.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | |
|---|---|---|
| Anchor Investor Reservation | 10,67,200 shares | 0 shares |
| Market Maker Reservation | 1,88,800 shares | 1,31,200 shares |
| QIB | 7,12,000 shares | 0 shares |
| NII | 5,34,400 shares | 12,44,800 shares |
| RII | 12,48,000 shares | 12,44,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,61,600 shares | 24,89,600 shares |
Aakaar Medical Technologies IPO subscribed 2.28x in total, whereas Solvex Edibles IPO subscribed 1.02x.
| Aakaar Medical Technologies IPO | Solvex Edibles IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 1.48x | 1.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.93x | 0.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.28x | 1.02x |
